Generic Darvocet 500 mg

Darvocet 500 mg Explained: What “A500” Meant and Why It Is No Longer Sold

Do not purchase or use Darvocet A500 in the United States. The name describes a former prescription product containing propoxyphene and acetaminophen. Propoxyphene products were removed from the U.S. market in 2010 after regulators determined that the risks—including serious effects on the heart’s electrical activity—outweighed the pain-relief benefit. An online offer for “Darvocet 500 mg” is not a route to a current FDA-approved medicine.

This page takes a label-first approach. It clarifies the confusing strength, distinguishes Darvocet A500 from Darvocet-N 100, explains the market withdrawal, and provides steps for patients who find old pills or need present-day pain care. The information is intended for U.S. readers researching Darvocet A500 ingredients, Darvocet 500 mg availability, propoxyphene withdrawal, or legitimate prescription alternatives. It is not a dosing guide and does not replace a clinician or pharmacist.

The Most Important Label Correction: A500 Did Not Mean 500 mg of Propoxyphene

Search results and abbreviated product titles often call the medicine “Darvocet 500 mg.” That phrasing can create a dangerous misunderstanding. The historical product was Darvocet A500, and each tablet contained two active ingredients:

• Propoxyphene napsylate 100 mg; and
• Acetaminophen 500 mg.

The “500” referred to acetaminophen. There was not 500 mg of propoxyphene in each A500 tablet. A person should never infer the ingredients of a combination medicine from a single number in a product title. The full generic name and strength of every component are necessary for safe identification.

Darvocet A500 was formerly supplied as a dark orange, film-coated, oval tablet marked “A500,” but appearance is historical reference information—not a method for authenticating a pill today. Counterfeiters can copy color and imprints. Old tablets can also be mixed into the wrong container. A pill that looks like an archived image is not thereby genuine or safe.

A500 Versus Darvocet-N 100

Both former products delivered 100 mg of propoxyphene napsylate. Their acetaminophen amounts differed. A500 contained 500 mg, while Darvocet-N 100 contained 650 mg. This comparison explains the names but does not make either product an option for current treatment.

Question	Darvocet A500	Darvocet-N 100
Propoxyphene napsylate per tablet	100 mg	100 mg
Acetaminophen per tablet	500 mg	650 mg
Meaning of the name’s number	“500” referenced acetaminophen	“100” referenced propoxyphene napsylate
U.S. market status	Withdrawn	Withdrawn

The distinction also shows why a page titled simply “Darvocet 500 mg” should state the complete 100 mg/500 mg historical composition. Without that clarification, a reader could mistake an acetaminophen amount for an opioid dose, compare unlike products, or add another acetaminophen medicine without recognizing duplication.

The Regulatory Turning Point

Darvocet A500 was once prescribed for mild to moderate pain. Its status changed after additional safety evidence became available. On November 19, 2010, the FDA recommended that healthcare professionals stop prescribing and dispensing propoxyphene-containing medicines and requested their withdrawal from the U.S. market.

The agency’s concern centered on clinically significant changes in cardiac conduction. Propoxyphene could alter electrocardiogram intervals involved in the timing and spread of electrical signals through the heart. These changes can increase the possibility of abnormal rhythms, including life-threatening events. Importantly, the findings occurred at therapeutic exposure; the problem could not be solved merely by warning patients not to misuse the medicine.

Propoxyphene also produced a metabolite called norpropoxyphene. Differences in metabolism, age, kidney function, liver function, other medicines, and repeated use could affect exposure. Alongside cardiac risk were familiar opioid hazards: sedation, respiratory depression, impairment, misuse, physical dependence, and fatal overdose. The acetaminophen component introduced an independent risk of severe liver injury when total daily intake became excessive.

Withdrawal means the risk-benefit judgment for the product changed. It is not equivalent to a temporary shortage, a packaging recall for one lot, or discontinuation solely for business reasons. Historic approval does not continue as a guarantee of safety after the medicine has been withdrawn.

A Transactional Reality Check for Online Shoppers

Someone searching “buy Darvocet A500 online,” “Darvocet 500 mg price,” or “generic Darvocet A500 delivery” may encounter storefronts displaying quantities, discounts, and shipping claims. Those commercial details do not resolve the central problem: Darvocet A500 is not a current U.S.-market product that a legitimate pharmacy should sell as newly dispensed stock.

Treat each of the following claims as a reason to leave the site:

• “No prescription required” for an opioid or other prescription-only product;
• “Guaranteed Darvocet approval” before a medical evaluation;
• Bulk pill packages inconsistent with an individualized prescription;
• Payment only by cryptocurrency, wire transfer, gift card, or person-to-person app;
• No verifiable physical pharmacy address or pharmacist;
• Use of a copied regulatory logo without a link to an official license record;
• International shipping that avoids normal prescription and customs requirements;
• Claims that a withdrawn product is “FDA approved today”; or
• A product description that calls A500 “500 mg propoxyphene.”

Do not provide a seller with identity documents, medical records, payment information, or a photo of an old prescription in an attempt to obtain Darvocet. A past prescription is not authorization to refill a withdrawn medicine indefinitely. If the goal is affordable pain treatment, begin with a current medical assessment and then compare lawful prices for the treatment actually prescribed.

Why “Generic Darvocet 500 mg” Does Not Solve the Safety Problem

A generic medicine ordinarily contains the same active ingredient and works in the same way as its reference product, subject to regulatory standards. But a generic name does not bypass a market withdrawal involving the active ingredient itself. Propoxyphene-containing generics were part of the U.S. withdrawal. Replacing the brand name with “propoxyphene napsylate and acetaminophen” does not turn the combination into a current safe option.

Likewise, “manufactured overseas,” “pharmaceutical grade,” “new old stock,” or “original formula” are not reassuring descriptions. Storage temperature and moisture may have been uncontrolled; the chain of custody may be unknown; the product may be expired; and the contents may be fraudulent. Even a chemically authentic tablet would retain the propoxyphene risk that led to withdrawal.

The appropriate comparison is therefore not brand versus generic Darvocet. It is a clinical comparison among current treatments for the diagnosed source of pain. That comparison belongs in a consultation and should account for expected benefit, side effects, medical history, interactions, cost, duration, and monitoring.

Two Ingredients, Two Different Toxicity Pathways

Propoxyphene: opioid and cardiac toxicity

Propoxyphene acted as an opioid analgesic in the central nervous system. Opioids can slow breathing and reduce alertness. Propoxyphene and its metabolite also affected cardiac ion channels, helping explain the electrocardiogram changes that drove the withdrawal. Combining it with alcohol, benzodiazepines, sleep medicines, other opioids, muscle relaxants, barbiturates, or other central nervous system depressants could intensify sedation and breathing suppression.

Danger signals after suspected exposure include inability to stay awake, slow or irregular breathing, blue or gray lips, collapse, seizure, severe dizziness, fainting, or an irregular heartbeat. Call 911 immediately. Naloxone may reverse the opioid part of an overdose, but it does not treat acetaminophen poisoning or every possible counterfeit ingredient. Emergency care remains necessary even if the person becomes responsive.

Acetaminophen: hidden duplication and liver injury

Each former A500 tablet added 500 mg of acetaminophen. Acetaminophen appears in many headache, dental, arthritis, cold, flu, and prescription pain products. Brand names can obscure duplication, and “APAP” may appear on a pharmacy label. Excess acetaminophen can cause acute liver failure, transplantation, or death.

FDA consumer information states that adults and children 12 years and older should not exceed 4,000 mg in 24 hours from all sources. That is a ceiling, not a recommended target; some patients need a lower limit. Liver disease, regular alcohol consumption, poor nutrition, older age, small body size, and other factors can affect risk. Anyone who may have taken more than directed should contact Poison Control promptly instead of waiting for abdominal pain or jaundice.

What an Overdose Can Look Like

A combined-product overdose does not always produce one obvious pattern. Opioid effects may appear as profound sleepiness, reduced breathing, pinpoint pupils, low blood pressure, or unresponsiveness. Propoxyphene-related cardiac toxicity may produce palpitations, conduction abnormalities, fainting, collapse, or sudden deterioration. Acetaminophen poisoning can initially resemble a stomach illness—or cause few early symptoms—while liver damage develops.

Because symptoms can be delayed or masked, home observation is not an adequate response to a suspected overdose. In the United States, call Poison Control at 1-800-222-1222 for immediate guidance. If the person has trouble breathing, cannot be awakened, has a seizure, collapses, or shows another life-threatening symptom, call 911. Do not induce vomiting, give food or drink unless instructed, or allow the person to “sleep it off.”

Provide the product name, tablet markings, estimated amount, time of exposure, age, weight, symptoms, and other substances taken. If safe, bring the container to the hospital. Do not delay the ambulance while searching for packaging.

What to Do With a Bottle Marked A500

Finding old Darvocet during a move, estate cleanout, or medicine-cabinet review calls for secure disposal—not resale or reuse. Keep the bottle closed and away from children, pets, visitors, and anyone at risk of self-harm or substance misuse. Do not place tablets loosely in household trash while a take-back option is available.

1. Confirm that no one has taken the medicine. If exposure is possible, contact Poison Control.
2. Move the bottle to a locked or otherwise secure temporary location.
3. Ask a local pharmacist about an authorized year-round collection kiosk or medication mail-back envelope.
4. Use the FDA- and DEA-supported take-back route whenever possible.
5. Remove personal information from the label before disposal when appropriate, without opening or handling the tablets unnecessarily.

Do not donate discontinued medicine to another patient. Do not mail it to a buyer or return it to an online seller. Sharing or selling prescription drugs is unsafe and may be illegal. If the bottle is part of an active poisoning, fraud, or counterfeit investigation, follow instructions from medical or law-enforcement personnel rather than disposing of evidence.

From a Darvocet Search to a Current Pain Assessment

People often remember a medicine that worked in the past and search for the same brand when pain returns. The memory is understandable, but the diagnosis may be different and the patient’s health may have changed. A safe plan begins with four questions:

1. What is causing the pain? Muscle strain, nerve pain, infection, fracture, inflammation, migraine, dental disease, and organ-related pain require different approaches.
2. How urgent is it? Sudden, severe, or neurologically complicated pain can require emergency evaluation rather than a pharmacy order.
3. What has already been tried? Include dose, duration, benefit, side effects, and why a treatment was stopped.
4. Which risks shape the choice? Heart, liver, kidney, lung, stomach, bleeding, pregnancy, fall, interaction, and substance-use risks all matter.

A clinician may recommend non-drug care, a non-opioid medicine, a topical product, targeted therapy, or—when justified—a current opioid under a defined plan. The objective is not necessarily to reproduce the sensation of a former medicine. It is to improve function and comfort while treating the underlying condition with the lowest reasonable risk.

Build a Useful Pain Record Before the Visit

A brief pain record can improve the quality of an in-person or telehealth consultation. Record onset, location, intensity, quality, pattern, triggers, relieving factors, and related symptoms. Describe functional impact: whether the pain prevents sleep, walking, work, eating, or self-care. Note previous injuries, operations, diagnoses, imaging, physical therapy, and medicines.

List every active product, including nonprescription acetaminophen, ibuprofen or naproxen, cold and allergy medicines, sleep aids, supplements, alcohol, and cannabis. Include the last time each was taken. This list helps the clinician detect duplicated acetaminophen, sedative combinations, bleeding risk, or kidney and liver concerns.

Tell the clinician why Darvocet A500 came to mind. If it previously relieved pain, say so. If it caused dizziness, constipation, excessive sleepiness, escalating use, or withdrawal, that information is equally important. A transparent history supports safer care and does not obligate the clinician to prescribe an opioid.

Current Prescription Purchasing: A Safer Checklist

Once a licensed professional has selected a current medicine, patients can compare pharmacy options without compromising safety. A legitimate pharmacy should require the prescription, use the exact drug and strength ordered, provide a labeled container, supply patient information, and make a pharmacist available. Verify online pharmacies through official state board records rather than relying on the store’s own badge.

Before paying, confirm:

• Whether the prescription is for a brand or generic medicine;
• The active ingredient, dose form, and strength;
• The quantity authorized and whether refills are permitted;
• The cash price, insurance price, and any legitimate discount option;
• Whether prior authorization is needed;
• The pickup or delivery schedule and storage needs; and
• How to contact the dispensing pharmacist with a concern.

Inspect the package when it arrives. Do not take a medicine if the patient name, drug, strength, directions, seal, or appearance is unexpected. Call the dispensing pharmacy using a verified number. For controlled medicines, do not leave the delivery unattended or allow another person to use it.

Special Situations That Need Professional Advice

Older adults may be more sensitive to sedation, falls, confusion, and drug accumulation. People with kidney or liver impairment may clear a medicine or its metabolites differently. Heart disease, arrhythmia history, fainting, electrolyte disturbances, and medicines that affect cardiac conduction are particularly relevant after suspected propoxyphene exposure. Lung disease, severe asthma, and sleep apnea increase concern about respiratory depression.

Pregnancy and breastfeeding require immediate professional guidance after taking a withdrawn or unknown medicine. Children require urgent Poison Control advice for any possible ingestion; do not wait for symptoms. People with depression, suicidal thoughts, or substance-use concerns should not be left alone with an old opioid supply. Secure the medicine, seek urgent support, and call emergency services when there is immediate danger.

Do Not Replace A500 With a Look-Alike Acetaminophen Product

Once patients learn that the “500” in A500 referred to acetaminophen, some assume a 500 mg over-the-counter acetaminophen tablet is a direct substitute. It is not. Acetaminophen was only one component of the old combination, and an appropriate modern pain plan depends on the condition. More importantly, taking acetaminophen without checking other products can lead to accidental duplication.

Review cough, cold, flu, sinus, sleep, menstrual, dental, arthritis, and prescription pain medicines for acetaminophen or APAP. Use the measuring device supplied with liquid medicine rather than a kitchen spoon. Do not alternate brands based on package color, and do not use more because pain persists. Continuing or escalating pain may be a signal that the diagnosis or treatment needs reassessment.

Nonsteroidal anti-inflammatory drugs such as ibuprofen or naproxen are also not universal substitutes. They may be inappropriate for some people with kidney disease, ulcers, bleeding risk, heart disease, anticoagulant use, or pregnancy. Topical products, physical therapy, and other non-drug measures have their own appropriate and inappropriate uses. “Available without a prescription” does not mean “safe for every patient.” Ask a pharmacist or clinician to review the full medical situation.

A Six-Point Framework for Comparing Current Pain Options

Rather than asking which medicine is “as strong as Darvocet,” compare current options across six dimensions:

1. Diagnosis fit: Does the treatment address inflammatory, nerve-related, musculoskeletal, dental, visceral, or postoperative pain?
2. Expected benefit: Is the realistic goal lower pain intensity, better mobility, improved sleep, or faster recovery?
3. Time horizon: Is the treatment intended for hours, several days, or longer-term management?
4. Patient risk: How do age, pregnancy, falls, heart disease, liver and kidney function, breathing disorders, and substance history affect the choice?
5. Interaction burden: Will the medicine duplicate acetaminophen, increase bleeding, add sedation, or conflict with another prescription?
6. Follow-up plan: When should benefit be assessed, what side effects need reporting, and when should treatment stop?

This framework avoids the false precision of comparing milligram numbers across unrelated medicines. Milligrams measure mass, not universal “strength.” Five hundred milligrams of acetaminophen, 100 mg of propoxyphene napsylate, and a small quantity of another drug cannot be ranked by the number alone. Pharmacology, formulation, route, and patient response determine effect.

How a Legitimate Online Consultation Should Work

Telehealth can be a convenient way to discuss some pain concerns, but it is not an automatic prescription service. A legitimate clinician should collect a meaningful history, verify identity and location, hold an appropriate license, review medications and contraindications, and decide whether remote care is sufficient. Some symptoms require physical examination, vital signs, imaging, laboratory testing, or emergency evaluation.

The service should not advertise a guaranteed opioid, promise Darvocet before the visit, or treat payment as evidence that a prescription is medically necessary. The clinician should explain the diagnosis or working assessment, treatment choices, foreseeable risks, and follow-up. If a controlled medicine is considered, federal and state prescribing requirements apply; those rules can change and may differ by location.

After the visit, a valid electronic prescription should go to a pharmacy chosen by the patient or otherwise clearly identified. The pharmacy—not an anonymous fulfillment center—should answer dispensing questions. A site that bundles an unknown consultation with unlabeled pills and international shipping breaks the normal accountability chain.

Product Quality Questions for Any Medicine Delivered to Your Home

Home delivery is not itself unsafe; many licensed pharmacies provide it. The concern is whether the product can be traced through a legitimate prescription and dispensing process. On receipt, inspect the outer package for damage and the pharmacy container for the patient name, pharmacy name and phone number, prescriber, drug name, strength, directions, quantity, and identifying information required in the jurisdiction.

Do not take the medicine when:

• The drug or strength differs from the current prescription;
• The label contains another patient’s name;
• Tablets are loose in an unmarked bag or blister;
• The tamper-evident seal is broken without explanation;
• The tablets differ substantially from the pharmacy’s description;
• The package arrived hot, wet, crushed, or contaminated; or
• The return address or pharmacy contact cannot be verified.

Call the dispensing pharmacy using a number independently confirmed from its official listing. Medication appearance can change between approved manufacturers, so a difference does not automatically mean counterfeit, but it should be resolved before the first dose. Never test a suspicious product by taste or by taking a partial tablet.

Recognizing When Pain Needs Diagnosis, Not a Stronger Pill

Repeatedly increasing pain medication can hide clinical deterioration. Dental pain with fever or facial swelling may require infection treatment. Back pain with new leg weakness, saddle numbness, or bladder changes may represent a neurologic emergency. Abdominal pain with rigidity, black stool, fainting, or persistent vomiting may need urgent evaluation. A sudden severe headache, headache after head injury, or headache with weakness or confusion should not be managed by ordering an old opioid.

Other reasons to seek prompt review include unexplained weight loss, night sweats, pain that wakes a person consistently, a new painful lump, redness spreading from a wound, chest pain with exertion, or pain in pregnancy. These examples are not exhaustive. When symptoms are severe, rapidly changing, or accompanied by systemic illness, use urgent or emergency care.

For stable pain, schedule follow-up if recommended treatment is not improving function, side effects are limiting use, or the medicine is needed longer than planned. A good care plan includes a stop point and reassessment; it should not drift into indefinite repeat purchasing.

Keep a Current Medication List After Disposing of Darvocet

Removing an old bottle is a good time to update the household medication list. Include active prescriptions, occasional medicines, vitamins, supplements, allergies, and the pharmacy used. Mark Darvocet as a discontinued historical medicine rather than leaving it among active treatments. Note any past adverse reaction, dependence concern, or reason it was stopped.

Share the updated list at medical, dental, urgent-care, and telehealth visits. Dentists and surgeons especially need to know about sedatives, anticoagulants, alcohol use, liver disease, and existing acetaminophen exposure before recommending postoperative pain treatment. Keep an emergency copy accessible, but protect sensitive information from unnecessary disclosure.

Medication reconciliation prevents a clinician from assuming an old drug is still being taken and helps pharmacists identify duplication. It also gives caregivers a reliable reference during an emergency when the patient may not be able to answer questions.

Questions and Answers About Darvocet A500

What was Darvocet A500 used for?

It was historically prescribed for mild to moderate pain. That former use does not override its current withdrawn status in the United States.

What were the Darvocet A500 ingredients?

Each historical tablet contained propoxyphene napsylate 100 mg and acetaminophen 500 mg.

Does “Darvocet 500 mg” mean 500 mg of opioid?

No. The 500 referred to acetaminophen. The propoxyphene napsylate amount was 100 mg. Product titles that omit the second strength can be misleading.

Is A500 stronger than Darvocet-N 100?

Both contained 100 mg of propoxyphene napsylate. A500 contained less acetaminophen—500 mg versus 650 mg in Darvocet-N 100. Neither should be used because propoxyphene products were withdrawn.

Can I order generic Darvocet A500 with a prescription?

A legitimate U.S. pharmacy should not dispense propoxyphene-acetaminophen as a current product. Ask the prescriber to choose a currently approved alternative appropriate for the diagnosed condition.

Why is Darvocet A500 still listed on some websites?

Pages may be outdated, may preserve historical drug information, or may be unverified sales listings. An available “add to cart” button does not establish legal or regulatory availability.

Is one old A500 tablet safe?

No old or withdrawn tablet should be assumed safe. If one has been taken, contact Poison Control for case-specific advice; call 911 for severe sleepiness, breathing difficulty, seizure, collapse, fainting, or inability to wake.

Can a pill imprint prove an A500 tablet is real?

No. Appearance can support historical identification, but it cannot establish chemical content, storage quality, or authenticity. Do not ingest a pill identified only from an image.

What is the best way to dispose of Darvocet?

An authorized drug take-back kiosk or mail-back program is preferred. A pharmacist can help locate one. Keep the medicine secured until it is transferred.

What should I ask for instead of Darvocet?

Ask for an evaluation of the pain and a current treatment plan, not a specific replacement pill. The best option depends on cause, urgency, duration, prior response, and individual risk factors.

Where can I compare the price of a current alternative?

After a medicine is prescribed, compare prices through licensed pharmacies, insurance tools, or legitimate discount programs. Verify the exact active ingredient, form, strength, and quantity so the comparison is accurate.

Is historical Darvocet information still useful?

Yes, when it is clearly labeled as historical. It can help a patient interpret an old medical record, recognize why a former medicine disappeared, report a past exposure, or dispose of an old bottle correctly. It should not be repurposed as current prescribing instructions. A responsible page must put the withdrawal status before commercial language, state both active ingredients, and direct readers toward current professional care.

What if an overseas website says Darvocet is legal in its country?

Medicine approval and controlled-drug rules differ across countries, but a foreign claim does not authorize importation, dispensing, or use in the United States. It also does not verify the seller, product, strength, or storage. U.S. readers should follow U.S. regulatory status and obtain treatment through clinicians and pharmacies licensed for their location.

Bottom Line for Patients and Caregivers

Darvocet A500 was a 100 mg propoxyphene napsylate and 500 mg acetaminophen combination. Calling it only “Darvocet 500 mg” hides half of the formulation and can make the strength look like 500 mg of opioid, which it was not. The complete product was withdrawn from the U.S. market because the risks of propoxyphene, including potentially serious cardiac toxicity, outweighed its benefit.

Do not buy Darvocet A500 online, take leftover tablets, or rely on an imprint to confirm safety. Use a take-back program for old stock. If pain needs treatment now, obtain a diagnosis-based plan from a licensed clinician and fill any current prescription through a verifiable pharmacy. For suspected exposure, contact Poison Control at 1-800-222-1222; use 911 for life-threatening symptoms.

Regulatory and Patient-Safety Sources

• Archived DailyMed propoxyphene napsylate 100 mg/acetaminophen 500 mg label
• Federal Register record of the FDA propoxyphene safety decision
• FDA guidance on acetaminophen safety
• FDA unused-medicine disposal information
• Poison Control